Biochemical and Sociodemographic Correlates of Major Depressive Disorder in Patients With Chronic Kidney Disease Receiving Hemodialysis

被引:1
|
作者
Kumar, Ashutosh [1 ]
Jain, Apoorva [2 ]
Rikhari, Praveen [1 ]
机构
[1] Sarojini Naidu Med Coll, Psychiat, Agra, Uttar Pradesh, India
[2] Sarojini Naidu Med Coll, Nephrol, Agra, Uttar Pradesh, India
关键词
ham-d; mdd; hemodialysis; depression; ckd; STAGE RENAL-DISEASE; PREVALENCE; DIALYSIS; ANXIETY; ASSOCIATION; MANAGEMENT; MORTALITY; SYMPTOMS;
D O I
10.7759/cureus.43267
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Chronic kidney disease (CKD) is a chronic disabling illness with multiple physical and psychosocial consequences. A major treatment modality for CKD is renal replacement therapy in the form of hemodialysis. A bidirectional relationship between depression and CKD is proposed, as depressive symptoms lead to poorer outcomes in CKD and vice versa. This study aimed to determine the prevalence of major depressive disorder (MDD) in CKD patients on maintenance hemodialysis and find any sociodemographic, clinical, or biochemical correlates. Material and methods This was a cross-sectional study conducted at a tertiary care teaching hospital in north India. We used clinical interviews for diagnosing MDD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). The severity was quantified using Hamilton Depression Rating Scale (HAM-D) in those diagnosed with MDD. Results A total of 77 patients were included in the study. The prevalence of MDD in patients with CKD undergoing hemodialysis was 31.17%, much higher than in the general population. Most of those who were depressed had moderate to severe depression. Male gender and lower socioeconomic status were significantly associated with the diagnosis of MDD. Those undergoing dialysis less frequently or having more work days lost due to CKD were more likely to be depressed. Additionally, patients with MDD were found to have significantly lower blood hemoglobin levels, lower serum ionized calcium levels, and a lower urea reduction ratio compared to those who did not have MDD. Conclusion The high prevalence of MDD in patients with CKD undergoing hemodialysis suggests that clinicians should actively evaluate for depressive symptoms in this patient population and refer them to mental health services when required, especially those with the above-identified sociodemographic and biochemical risk factors.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, adult outpatients with major depressive disorder
    Srisurapanont, M.
    Likhitsathian, S.
    Chua, H. C.
    Udomratn, P.
    Chang, S.
    Maneeton, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S385 - S385
  • [42] Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease
    Fischer, Michael J.
    Kimmel, Paul L.
    Greene, Tom
    Gassman, Jennifer J.
    Wang, Xuelei
    Brooks, Deborah H.
    Charleston, Jeanne
    Dowie, Donna
    Thornley-Brown, Denyse
    Cooper, Lisa A.
    Bruce, Marino A.
    Kusek, John W.
    Norris, Keith C.
    Lash, James P.
    KIDNEY INTERNATIONAL, 2010, 77 (11) : 1010 - 1019
  • [43] Early prediction of clinical response in patients with major depressive disorder receiving fluoxetine
    Lin, C. H.
    Lin, K. S.
    Chen, M. C.
    Chou, L. S.
    Chen, C. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S335 - S335
  • [44] PREVALENCE OF MAJOR DEPRESSIVE EPISODE AMONG PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE
    Sumanathissa, Manannalage
    de Silva, Varuni A.
    Hanwella, Raveen
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2011, 41 (01): : 47 - 56
  • [45] Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis
    Ping Chen
    Adimoolam Narayanan
    Benjamin Wu
    Per Olsson Gisleskog
    John P. Gibbs
    Andrew T. Chow
    Murad Melhem
    Clinical Pharmacokinetics, 2018, 57 : 71 - 85
  • [46] Dose conversion from epoetin alfa to darbepoetin alfa for patients with chronic kidney disease receiving hemodialysis
    Barnett, AI
    Crémieux, PY
    PHARMACOTHERAPY, 2003, 23 (05): : 690 - 693
  • [47] Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis
    Chen, Ping
    Narayanan, Adimoolam
    Wu, Benjamin
    Gisleskog, Per Olsson
    Gibbs, John P.
    Chow, Andrew T.
    Melhem, Murad
    CLINICAL PHARMACOKINETICS, 2018, 57 (01) : 71 - 85
  • [48] Prevalence of Chronic Kidney Disease-Mineral Bone Disorder in Hemodialysis Patients in Hebei, China
    Jin, Jing-Jing
    Zhang, Sheng-Lei
    Xu, Jin-Sheng
    Cui, Li-Wen
    Zhang, Hui-Ran
    Bai, Ya-Ling
    CHINESE MEDICAL JOURNAL, 2018, 131 (22) : 2749 - 2751
  • [49] Prevalence of Chronic Kidney Disease-Mineral Bone Disorder in Hemodialysis Patients in Hebei, China
    Jin JingJing
    Zhang ShengLei
    Xu JinSheng
    Cui LiWen
    Zhang HuiRan
    Bai YaLing
    Department of Nephrology The Fourth Hospital of Hebei Medical University Shijiazhuang Hebei China
    中华医学杂志英文版, 2018, 131 (22) : 2749 - 2751
  • [50] Sleep disorder in patients receiving hemodialysis
    El Khattabi, Wiam
    Janah, Hind
    Jabri, Hasna
    Afif, Hicham
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46